VivoSeq
Ophthalmology

Corneal Edema

6

Pipeline Programs↗

0

Active Trials↗

6

Companies Involved↗

Corneal Edema is an early-stage landscape with 6 programs across 6 companies. The most active players are Falcon, AbbVie, SpyGlass Pharma, Inc.. 2 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

0/100

Mech. Concentration

67/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Falcon

1 program

Phase 2AbbVie logo

AbbVie

2 programs

Phase 3S

SpyGlass Pharma, Inc.

1 program

Phase 3M

Milestone Pharmaceuticals Inc.

1 program

ApprovedF

Fovea Pharmaceuticals SA

1 program

ApprovedA

Aerie Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed6 · 86%
Unknown status1 · 14%

Clinical Trials

Trial Activity

7 trials

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Completed·AAerie Pharmaceuticals·Phase 2·NCT04498169·40 enrolled
Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema
Completed·EEye-yon Medical·N/A·NCT01890252·9 enrolled
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Completed·EEmmecell·Phase 1·NCT04894110·42 enrolled
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
Completed·—·Phase 4·NCT01244334·52 enrolled
Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema
Completed·EEye-yon Medical·N/A·NCT02660151·68 enrolled
Rhopressa for Corneal Edema Associated With Fuchs Dystrophy
Completed·PPrice Vision Group·Phase 2/3·NCT04051463·29 enrolled
Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Unknown status·RRabin Medical Center·Phase 3·NCT00800423·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)